Methocarbamol
- Product NDC
- 63739-992
- 11-digit product format
- 637390992
- Labeler code
- 63739
- Product ID
- 63739-992_c7bc55bf-4d5f-682b-e053-2995a90af285
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methocarbamol Tablets
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- McKesson Corporation dba SKY Packaging
- Application
- ANDA209312
- Marketing category
- ANDA
- Marketing start
- 2021-07-22
- Marketing end
- 0000-00-00
- Substance
- METHOCARBAMOL
- Active strength
- 750 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 63739-992 | D | Discontinued by firm | 2026-07-31 | ||
| excluded package | package | 63739-992 | 63739-992-10 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209312-001 | METHOCARBAMOL | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 |
| A209312-002 | METHOCARBAMOL | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209312-001 | AA |
| A209312-002 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209312-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | RS | 2018-05-07 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209312-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | RS | 2018-05-07 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209312-001 | AA | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209312-002 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 52b20439-6bf4-435e-817a-c3b3fc70846a | 2026-07-10 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 37767123-8b72-4e1f-b00d-ff3305e9923f | 2026-07-10 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Unit Dose Solutions, Inc. | 561ae476-9e1f-038a-e063-6394a90aa5c7 | 2026-07-08 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Granules Pharmaceuticals Inc. | 6f0d3966-962d-fa7c-e053-2a91aa0a8e3c | 2026-07-07 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Bryant Ranch Prepack | 65c460f6-6470-41ff-abb4-d9d54ecc52f7 | 2026-07-06 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | St. Mary's Medical Park Pharmacy | 7d4dd78a-f902-6ff2-e053-2991aa0ac7d7 | 2026-06-26 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Preferred Pharmaceuticals Inc. | 43f83b87-e169-46fe-98bd-6af373595bd3 | 2026-06-23 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Preferred Pharmaceuticals Inc. | e03878d3-d780-4e7f-b828-20ac2a109933 | 2026-06-23 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Coupler LLC | 52b87514-e6e0-ab57-e063-6394a90a6b23 | 2026-05-26 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 71c21226-cd96-33ed-e053-2995a90a5269 | 2026-05-22 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | St. Mary's Medical Park Pharmacy | faa81ad3-2bd2-d637-e053-6294a90a2d36 | 2026-05-10 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Proficient Rx LP | 23163bc1-dec7-41f6-baed-eedebfd6be7e | 2026-05-01 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 1dc3a5b1-c83b-406b-a59d-ce8075e4ccf9 | 2026-04-28 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Advanced Rx of Tennessee, LLC | 4de118fe-bd8e-6cc4-e063-6394a90a1320 | 2026-03-25 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Advanced Rx of Tennessee, LLC | 4cefe51c-d824-a862-e063-6394a90a7717 | 2026-03-13 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Redpharm Drug | 44f264fd-bf40-bed9-e063-6294a90ac44a | 2026-03-05 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 72f36d28-15d2-30f6-e053-2a91aa0ad1ce | 2026-01-30 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Northwind Health Company, LLC | f2b4ed95-0469-393a-e053-2a95a90a98ed | 2026-01-19 | Warnings, Adverse reactions | 209312 ANDA209312 |
| METHOCARBAMOL | METHOCARBAMOL | DIRECT RX | 31508051-c9cb-149b-e054-00144ff88e88 | 2026-01-08 | Warnings, Adverse reactions | 209312 ANDA209312 |
| Methocarbamol | METHOCARBAMOL TABLETS | Northwind Health Company, LLC | f2b4ed5f-3489-9ee4-e053-2995a90a25f0 | 2026-01-01 | Warnings, Adverse reactions | 209312 ANDA209312 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63739-992-10 | EA - Each | 63739-992 | 5e4d770a-2ad7-47d3-89c3-938d040ae321 | 1 | 2021-09-07 |
DailyMed Dashboard NDC Coverage#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63739-992-10 | 63739099210 | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-992-10) > 10 TABLET, COATED in 1 BLISTER PACK | 10 blister pack | 2021-07-22 | 0000-00-00 | No | No | Current |